FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

787732000: Risankizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3776694016 Risankizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3776695015 Risankizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4357471000052117 risankizumab sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risankizumab Is a Substance with interleukin 23 receptor antagonist mechanism of action (substance) true Inferred relationship Some
Risankizumab Has disposition (attribute) Interleukin 23 receptor antagonist (disposition) true Inferred relationship Some
Risankizumab Is a murin-human monoklonal IgG-antikropp false Inferred relationship Some
Risankizumab Is a Immunosuppressant (substance) true Inferred relationship Some
Risankizumab Is a Monoclonal antibody true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing risankizumab (medicinal product) Has active ingredient True Risankizumab Inferred relationship Some 1
Risankizumab-containing product in parenteral dose form Has active ingredient True Risankizumab Inferred relationship Some 1
Risankizumab only product in parenteral dose form Has active ingredient True Risankizumab Inferred relationship Some 1
Risankizumab only product Has active ingredient True Risankizumab Inferred relationship Some 1
Risankizumab 150 mg/mL solution for injection Has precise active ingredient True Risankizumab Inferred relationship Some 1
Risankizumab 150 mg/mL solution for injection Has basis of strength substance (attribute) True Risankizumab Inferred relationship Some 1
Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Risankizumab Inferred relationship Some 1
Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Risankizumab Inferred relationship Some 1

This concept is not in any reference sets

Back to Start